Scarica l'app Stockscreener
5.65
11.16%
-0.71
Dopo l'orario di chiusura:
5.78
0.13
+2.30%
Emergent Biosolutions Inc Borsa (EBS) Ultime notizie
Emergent BioSolutions Inc.'s (NYSE:EBS) Share Price Boosted 29% But Its Business Prospects Need A Lift Too - simplywall.st
Emergent BioSolutions (EBS) Q1 2025 Earnings Highlight Turnaroun - GuruFocus
Emergent Biosolutions Q1 2025 Earnings Preview - MSN
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2025 Earnings Call Transcript - Insider Monkey
Emergent biosolutions reaffirms 2025 revenue guidance of $750M-$850M amid turnaround progress - MSN
Emergent BioSolutions Inc. SEC 10-Q Report - TradingView
Emergent Biosolutions: Q1 Earnings Snapshot - Norwalk Hour
Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... - Yahoo Finance
Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid Revenue Challenges - GuruFocus
Earnings call transcript: Emergent BioSolutions Q1 2025 sees 656% net income rise - Investing.com Nigeria
Emergent Biosolutions earnings beat by $0.22, revenue fell short of estimates - Investing.com
Emergent Biosolutions Q1 2025 slides: turnaround progress drives profitability By Investing.com - Investing.com India
Emergent BioSolutions Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - Yahoo Finance
Emergent BioSolutions Reports 656% Net Income Surge - TipRanks
Emergent BioSolutions (EBS) Updates 2025 Financial Forecast | EBS Stock News - GuruFocus
Emergent BioSolutions (EBS) Reports Strong Q1 Revenue | EBS Stock News - GuruFocus
Emergent BioSolutions Reports First Quarter 2025 Financial Results - The Manila Times
Earnings Flash (EBS) Emergent Biosolutions Posts Q1 Adjusted EPS $0.71, vs. FactSet Est of $0.44 - marketscreener.com
Emergent BioSolutions reports shareholder vote results By Investing.com - Investing.com Nigeria
Emergent BioSolutions Stockholders Elect Directors at Meeting - TipRanks
Emergent BioSolutions reports shareholder vote results - Investing.com
Emergent BioSolutions Inc expected to post earnings of 44 cents a shareEarnings Preview - TradingView
Naloxone Market Rises with Government Initiatives to Combat Opioid Overdose | Emergent BioSolutions, Hikma, Teva - openPR.com
Emergent signs contract to supply Narcan nasal spray in Ontario - Seeking Alpha
Emergent BioSolutions Gets $65M Deal for Ontario Naloxone Program - MarketWatch
Emergent BioSolutions (EBS) Secures $65M Deal with Ontario for N - GuruFocus
Emergent BioSolutions Reinforces Commitment to Opioid Emergency - GuruFocus
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health - The Manila Times
Emergent BioSolutions Lands Major $65M Deal: Ontario Chooses NARCAN to Fight Opioid Crisis - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times
Emergent BioSolutions Inc. to Host Conference Call on Q1 2025 Financial Results - Nasdaq
Save The Date: Emergent BioSolutions Q1 2025 Earnings Conference Call Coming May 7 - Stock Titan
Lobbying Update: $920,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed - Nasdaq
Emergent BioSolutions ($EBS) Is Paying a $40M Settlement to Investors — Here’s How to Get Your Share - TradingView
Institutional investors in Emergent BioSolutions Inc. (NYSE:EBS) see US$31m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Emergent BioSolutions launches stock repurchase program - MSN
Mile Marker Continues New Business Success With Growth-Oriented Brands - Yahoo Finance
ROSEN, A TOP RANKED LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline – EBS - Business Wire
Emergent BioSolutions sets $50 million stock buyback plan By Investing.com - Investing.com South Africa
Emergent BioSolutions Authorizes $50 Million Stock Buyback Program - MarketScreener
Emergent BioSolutions Announces Repurchase Of Up To $50 Mln Stock, Pre-market Stock Up - Nasdaq
Emergent BioSolutions sets $50 million stock buyback plan - Investing.com
0.82%
1.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):